Given that SMYD2 has also been linked to the development of metabolic‐associated steatotic liver disease (Wang et al., 2023), we predict that SMYD2 plays a role in regulating metabolic adaptations caused by sudden reductions in bioenergetic demand. This evidence concerns the gene SMYD2 and liver disorder.